Dr Pinakin R Jethwa, MD | |
512 Warren Ave, Spring Lake, NJ 07762-1233 | |
(973) 541-8065 | |
(973) 860-4317 |
Full Name | Dr Pinakin R Jethwa |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 17 Years |
Location | 512 Warren Ave, Spring Lake, New Jersey |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427253665 | NPI | - | NPPES |
0412121 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 25MA08693500 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jersey Shore University Medical Center | Neptune, NJ | Hospital |
Ocean Medical Center | Brick, NJ | Hospital |
Entity Name | Apex Neurospine Institute Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356935852 PECOS PAC ID: 6002224615 Enrollment ID: O20210421000057 |
News Archive
Researchers at Cold Spring Harbor Laboratory (CSHL) have solved an important piece of one of neuroscience's outstanding puzzles: how progenitor cells in the developing mammalian brain reproduce themselves while also giving birth to neurons that will populate the emerging cerebral cortex, the seat of cognition and executive function in the mature brain.
Malaria, a pathogen transmitted into blood by mosquitoes in tropical climates, is typically thought of as a blood and liver infection.
Researchers from the Epigenetics and Cancer Biology Program led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic leukemia.
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Pinakin R Jethwa, MD 858 Ridgewood Rd, Millburn, NJ 07041-1443 Ph: (973) 541-8065 | Dr Pinakin R Jethwa, MD 512 Warren Ave, Spring Lake, NJ 07762-1233 Ph: (973) 541-8065 |
News Archive
Researchers at Cold Spring Harbor Laboratory (CSHL) have solved an important piece of one of neuroscience's outstanding puzzles: how progenitor cells in the developing mammalian brain reproduce themselves while also giving birth to neurons that will populate the emerging cerebral cortex, the seat of cognition and executive function in the mature brain.
Malaria, a pathogen transmitted into blood by mosquitoes in tropical climates, is typically thought of as a blood and liver infection.
Researchers from the Epigenetics and Cancer Biology Program led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic leukemia.
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.
› Verified 9 days ago